Amazon Faces Allegations Over Millions in Profits from NowIllegal Pricing Policy Microsoft and Anthropic in Talks for Custom AI Chip Supply After 5 Billion Investment US Official Highlights Japans Role in Fentanyl Smuggling Route Raising Trade Security Concerns SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom Market Digest Allstate Electronic Arts Packaging Corp of America Sector Moves in Focus India and South Korea Aim to Address Widening Trade Deficit in CEPA Renegotiation Talks ESS Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges CRK Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges HAYW Q1 2026 Earnings EPS Surpasses Estimates by 1414 as Stock Declines Slightly ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Negative EPS Highlights Operational Strain as Bond Price Edges Higher Colony Bankcorp CBAN Edges Lower as Shares Approach Key Support Level ArrowMark Financial Corp BANX Holds Near Support as Slight Downtick Persists GRAIL Inc GRAL Advances Over 35 as Momentum Tests Key Resistance Zone Ames National Corporation ATLO Edges Lower as Price Action Remains RangeBound ARKO Petroleum Corp APC Stock Slips Nearly 2 as Shares Approach Key Support Czech Scientists Develop ClimateResilient Hops to Protect Signature Beer Flavor UK Exports to US Tumble 25 as Trump Tariffs Reshape Trade Dynamics Firefly FLY Stock Surges 15 on Rosy Space Sector Outlook Traders on Prediction Markets See Rising Odds of Fed Rate Hike by July 2027 Vanguard Dividend Appreciation ETF vs Fidelity High Dividend ETF Weighing Yield Fees and Performance Government Plans Up to 2 Stake Sale in LIC Potentially Raising Rs 10000 Crore IBMs Quantum Leap 27 Billion Market Cap Surge After Federal Quantum Computing Investment OGEN Q2 2023 Earnings EPS Surprise Beats Estimates Amid No Revenue Cash Burn Concerns Akebia Therapeutics AKBA Edges Higher Testing Key Resistance Near 111